Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study
Clinical & Experimental Ophthalmology · 2023
DOI: 10.1111/ceo.14226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Ophthalmology, 2023. Verfasst von Keke Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Phacoemulsification, Lenses, Intraocular. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission, The National Natural Science Foundation of China, Clinical Science and Technology Innovation Project of Shanghai Shenkang Hospital Development Center.
Abstract (Originalsprache)
Background
A new foldable brown diaphragm intraocular lens (IOL) was preclinically evaluated in vitro and in vivo by comparing its biocompatibility and biosafety with those of a commercially available IOL.
Methods
The new foldable iris‐diaphragm IOL is composed of hydrophobic acrylic material, with a transparent optical zone and surrounding brown diaphragm. Cellular experiments evaluating lens epithelial cell morphology, adhesion, and migration were conducted to exclude cytotoxic effects. Twelve New Zealand rabbits underwent implantation of a brown diaphragm IOL in one eye, whilst an additional 12 had a commercially available foldable IOL implanted, followed by slit‐lamp evaluations of inflammatory reactions and capsular opacification. Corneal endothelial cells density was measured before and after implantation. Aqueous humour samples were obtained weekly for liquid chromatography–tandem mass spectrometry (LC–MS/MS) analysis to investigate dye leakage from the brown‐diaphragm IOL. Following 12 weeks of observation, haematoxylin and eosin staining of ocular tissue and scanning electron microscopy (SEM) of the IOL surface were performed.
Results
Results from in vivo experiments found no statistically significant differences between the two groups in terms of postoperative inflammation and capsular biocompatibility. No significant changes in corneal endothelial cell density were observed in either group before and after surgery. LC–MS/MS analysis showed that the target dye was not detected in aqueous humour samples. Histopathology of ocular sections and SEM imaging of IOL surfaces showed similar changes in both groups.
Conclusions
The newly invented IOL showed good biocompatibility and biosafety. Combined with its foldability and peripheral shading, it could be a new choice for patients with iris defects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
- NHC Key Laboratory of Myopia (Fudan University), Shanghai, China.
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
- Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University, Shanghai, China.
- State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China.
ORCID-Profile: Yi Lu, Xiangjia Zhu
Förderung
- Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission
- The National Natural Science Foundation of China
- Clinical Science and Technology Innovation Project of Shanghai Shenkang Hospital Development Center
- Shanghai Municipal Key Clinical Specialty
- Science and Research Fund of Shanghai Health and Family Planning Commission
- National Natural Science Foundation of China
Zitieren
APA
Zhang, K., Zhang, S., He, W., Lu, Y., & Zhu, X. (2023). Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14226
Vancouver
Zhang K, Zhang S, He W, Lu Y, Zhu X. Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study. Clinical & Experimental Ophthalmology. 2023. doi:10.1111/ceo.14226
BibTeX
@article{Zhang2023,
author = {Zhang, Keke and Zhang, Shaohua and He, Wenwen and Lu, Yi and Zhu, Xiangjia},
title = {Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study},
journal = {Clinical & Experimental Ophthalmology},
year = {2023},
doi = {10.1111/ceo.14226}
}
EUVIMED